Losortan Potassium
Product Images NDC 53808-1072

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 53808-1072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 50mg (Losartan 50mg)

Losartan Potassium 50 mg tablets label showing quantity of 60 tablets. The label includes lot number, expiration date, and indicates the product is packaged by DOH Central Pharmacy in Tallahassee, Florida. It features a barcode and is marked for prescription use only (RX Only).*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 01)

Chemical structure of Losartan Potassium displayed as a molecular diagram with labeled atoms and functional groups, illustrating the arrangement of the active ingredient in the product by State of Florida DOH Central Pharmacy.*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 02)

A line graph comparing the percentage of patients with the primary endpoint over 66 study months for Atenolol (dashed line) and Losartan Potassium (solid line). The graph includes a note on adjusted risk reduction of 13% with p=0.021.*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over 66 months between two groups: one treated with Atenolol (dashed line) and the other with Losartan Potassium (solid line). The graph shows a lower percentage for Losartan Potassium throughout the study period and indicates an adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 04)

A forest plot comparing Losartan-K and Atenolol on primary composite and stroke (fatal/non-fatal) outcomes. It displays hazard ratios with 95% confidence intervals across various patient subgroups including age, gender, race, ISH, diabetes status, and history of cardiovascular disease, showing event rates and favored treatment per subgroup.*

FDA Label Image

Structure Product Formula For Losartan (Losartanpotasiumtabs Figure 05)

A line graph depicting the percentage of patients with an event over 48 months for Losartan Potassium Tablet versus placebo. The graph shows two lines: a solid line for Losartan Potassium Tablet and a dotted line for placebo, with a reported risk reduction of 16.1% and p-value of 0.022.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.